Try our beta test site

Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2012 by University of Cincinnati.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Olivier Rixe, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT01508117
First received: January 6, 2012
Last updated: January 10, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)